Instructions for posters:
- Authors of posters are totally free in the design of their posters.
- The size of the poster should not exeed the format A0 tall (width 84,1 cm x height 118,9 cm).
- The posters will be presented throughout the congress.
- This will allow participants to read the posters during coffee breaks.
- There will be two special poster sessions – one on Thursday (19.9.2024) and one on Friday (20.9.2024).
- The posters will be divided into two groups.
- During the poster sessions the poster authors must be present directly at the poster.
Poster session 1: Thursday, 19.9.2024, 14:00 – 15:30, first floor
| Poster number | Abstract Number | Title | Presenting Author |
| 1 | 220 | Norecopa: PREPARE for better Science | Adrian Smith |
| 2 | 29 | Establishing a culture of care environment through knowledge exchange – a project to increase mutual understanding leading to better results in health and research | Patrizia Gibler |
| 3 | 243 | Moral Case Deliberation (MCD) sessions within an animal facility | Sophie Schober |
| 4 | 53 | The Effect of Clicker Training on the Acute Physiological Stress Response in C57BL/6J Mice | Dorothea Pichl |
| 5 | 104 | Addressing pitfalls in animal behavior measurement through refinement in anxiety studies with meta-analysis | Özge Çevik |
| 6 | 75 | Recommendations for scientific fish husbandry | Bianka Grunow |
| 7 | 156 | Indicators for 3R monitoring in Switzerland | Aude Rapet |
| 8 | 128 | Innovation in Action: Collaboration between the Austrian 3R Center and Government Initiatives | Birgit Reininger-Gutmann |
| 9 | 92 | 3R-Competence Network North Rhine-Westphalia – The alliance for medical progress in line with the best possible animal welfare | Michael To Vinh |
| 10 | 210 | 3Rs in focus – how to make researchers more aware? | Györgyi Szabó |
| 11 | 173 | The introduction of alternative in vitro methods in the laboratory practicals | Tijana Markovič |
| 12 | 97 | A manifesto from the young generation advocating to go animal testing-free | Julia Menon |
| 13 | 195 | New paving stones for the road towards an animal free regulatory system: INSIGHT and CHIASMA | Martin Paparella |
| 14 | 90 | Prioritizing non-animal methods to improve environmental risk assessment for pharmaceuticals and promote innovation in the EU | Christopher Faßbender |
| 15 | 196 | Combining Education and Research: Replacement of Fetal Calf Serum for routine cell culture purposes | Jeffrey Bajramovic |
| 16 | 147 | Start the transition to animal-free antibodies for your research | Esther Wenzel |
| 17 | 50 | MONOCYTE ACTIVATION TEST (MAT) AS POTENTIAL ASSAY FOR QUALITY CONTROL OF VETERINARY AUTOGENOUS VACCINES: PRELIMINARY DATA | Rosario Liberti |
| 18 | 8 | Enhancing Atlantic Sturgeon Stem Cell Culture: Assessing Serum Reduction and Growth Factor Substitution Effects | Valeria Di Leonardo |
| 19 | 167 | Development of a defined foetal calf serum-free medium for differentiated HepaRG® cell culture – cancelled | Agnes Jamin |
| 20 | 69 | Comparative Proteomic Characterization of serum-free cultivated HepG2 cells reveals upregulated drug metabolism and increased oxidative stress protection | Luisa-Marie Pfeifer |
| 21 | 168 | Designing new fluorescent probes for efficient monitoring of drug-induced liver injury effects on bile canaliculi motility and albumin expression | Pamela Bachour-El Azzi |
| 22 | 123 | Effect of nephro- and hepatotoxins on precision cut tissue slices as a potential 3R-compliant method to assess organ toxicity | Nicole Schupp |
| 23 | 241 | Adverse outcome pathways to unravel drug-induced toxicity | Charline Sommer -YSTA awardee |
| 24 | 82 | Establishment of 3D FCS-free cultures of human proximal tubule epithelial cells | Stan Zuidervaart -YSTA awardee |
| 25 | 184 | Proliferation and differentiation capacity of an in vitro cell line model for myelopoiesis adopted to chemically-defined media | Pascal Woitschewski |
| 26 | 77 | Advancing Ethical and Reproducible Stem Cell Culture: Alternatives to Chemically Undefined Animal-Derived Matrices in in vitro Toxicology Testing | Julia Spänle |
| 27 | 126 | Animal free biomimetic fibrous scaffolds for the setup of 3D multi-layered epithelial models | Christina Fey |
| 28 | 56 | Non-invasive Monitoring of Three-Dimensional Tumor Spheroids using Electrical Impedance Spectroscopy | Ahmed Khattab |
| 29 | 232 | Unveiling the Dynamics of Scratch Assays: Continuous, Label-Free Monitoring of Cell Migration Using Lensfree Imaging and AI | Anna Jötten |
| 30 | 187 | Evolvoid: A Biophysical-Inspired Genetic Algorithm for Optimal Cellular Construct Design towards Lab-on-a-Laptop | Flavio Fontana |
| 31 | 198 | Nebuloid: a novel in silico agent-based cell model | Piera Mancini |
| 32 | 201 | Latest advancements in the use of in silico methods for the qualification of non-genotoxic impurities | Christian Novello |
| 33 | 137 | Animal-free optimization of energy delivery in cardiac Radiofrequency ablation: A virtual human study | Minha Anees |
| 34 | 72 | Modeling and analysis of standard-of-care vs. experimental, oncogene-specific therapeutic protocols in human digestive system cancers organoids | Albert Gandurski |
| 35 | 141 | MUG-hOSEC: A Human Ex Vivo Skin Model Breaking Boundaries | Beate Rinner |
| 36 | 136 | Autologous co-culture tumor models: Novel Therapeutic Approaches for Cholangiocarcinoma | Christina Karner |
| 37 | 131 | Autologous co-culture tumor models: „Novel Therapeutic Approaches for Clear Cell Sarcoma | Djenana Vejzovic – YSTA awardee |
| 38 | 160 | Autologous co-culture tumor models: Correlation of lipid signatures with drug resistance in CIC::DUX4 sarcoma cell line | Djenana Vejzovic – YSTA awardee |
| 39 | 245 | Evaluation and Integration of Blood-Brain Barrier In Vitro Models in a Safety and Sustainability Assessment Framework within the project CHIASMA | Duygu Turan Sorhun |
| 40 | 79 | Exploring Neuron-Mediated Chronic Pain: Insights from In vitro Modelling for Pharmacology and Toxicology | Kathrin Lämmerhirt |
| 41 | 148 | Stem cell-derived human brain tissue to study invasion mechanisms of primary brain tumors | Youcef Dahmani |
| 42 | 154 | Optimization of the synaptosome model to reduce tissue requirement and its application to examine the role of neural RAS | Zoltán Lincmajer |
| 43 | 207 | Water soluble Propolis Greit 120 and HuIFN-αN3 shows anti – Influenza virus activity in vitro | Bratko Filipič |
| 44 | 46 | Innovative therapy of influenza and respiratory infections caused by viruses through the use of siRNAs (shortinterfering RNAs) | Aurora De Mattia |
| 45 | 25 | Towards porcine enteroid cultures for rotavirus studies | Elena Ferrari |
| 46 | 247 | Development of an alternative method to animal experiments using a physical stimulation model for osteoarthritis | Katsuko Furukawa |
| 47 | 44 | Investigating the systemic distribution of implant wear products in ovo using the hen`s egg as a model | Laura Selle |
| 48 | 226 | Development of an in vitro test method for irritation of medical devices used in the oral cavity | Marek Puskar |
| 49 | 158 | Development of experimental setup based on a tissue-engineered 3D-cell phantom to evaluate Electroporation | Noah Müller |
| 50 | 48 | An in vitro method for anti-hair loss efficacy testing | Shujun Cheng |
| 51 | 49 | An in vitro method for anti-glycation efficacy in cosmetics | Shujun Cheng |
| 52 | 162 | In vitro phototoxicity assays – limitations and benefits of a combined approach to compound testing | Ulrike Theisen |
| 53 | 165 | Impedance-based identification of severe and mild eye irritation in vitro | Nicola Knetzger |
Poster session 2: Friday, 20.9.2024, 14:00 – 15:30, first floor
| Poster number | Abstract Number | Title | Presenting Author |
| 1 | 76 | Human stem cell-derived neurospheres as a model to characterize the impact of Listeria monocytogenes infection on early brain development | Annika Fischer -YSTA awardee |
| 2 | 155 | The investigation of synaptic monoamine uptake in rat brain synaptosomes | Dóra Lóska |
| 3 | 186 | DNT-RAP4: Pioneering Non Animal Methods-Based DNT Risk Assessment of Pesticides engaging EFSAs AOP based IATA approach via four new case studies | Ishita Virmani |
| 4 | 117 | Myelin matters: Development of a human stem cell-based peripheral myelin toxicity assay for regulatory testing | Lisa Haiber |
| 5 | 78 | Body-on-a-Chip Technologies Towards Neurotoxic Monitoring and Environmental Safety/CBRN Applications | Mateo Vasconez Martinez |
| 6 | 179 | Measuring metabolism in whole-brain organoids | Sonia Cerchio |
| 7 | 130 | Integration of the Blood-Brain Barrier and Brain Organoids in a Modular Microfluidic Platform for Sensor-Based Analysis in Drug Screening and Disease Modeling Applications | Sophie Schweinitzer – Physicians Committee for Responsible Medicine YSTA awardee |
| 8 | 224 | Translation of an Established in vitro Blood-Brain Barrier Differentiation Protocol to CRISPR/Cas9 Gen-Edited, Patient-derived hiPSC Lines: Highlighting Challenges | Nikoletta Kardos-Török -YSTA awardee |
| 9 | 249 | Label-free functional analysis for the characterization of iPSC-derived neural organoid development and maturation | Timm Schlegel |
| 10 | 250 | Evaluation of plate-to-plate reliability in a label-free cytotoxicity assay for dose response analysis | Timm Schlegel |
| 11 | 40 | In-vitro ion-channel dependent neurotoxicity evaluation using a series of Ion-channel stable overexpression cells | Shujun Cheng |
| 12 | 57 | IN-DEPTH PROTEOMIC PROFILES OF HIPSC-DERIVED EARLY RETINAL ORGANOIDS | Anna Bassi |
| 13 | 98 | Development of a dual-flow microfluidic device to study the interaction of the intestinal epithelium and the enteric nervous system | Alexandra Lorenz |
| 14 | 251 | P38 MAPK as a potential target to prevent IL-6/IL-22 induced leaky gut in Caco-2 cell model | Nikolai Leinz |
| 15 | 182 | Mucoadhesive magnetic nanoparticles for restoration of intestinal function in childhood visceral myopathy | Paolo Signorello |
| 16 | 225 | In vitro 3D reconstructed models of human duodenum, jejunum and ileum | Silvia Letasiova |
| 17 | 222 | EpiOcularTM time-to-toxicity – a test method for subcategorization of eye irritants | Silvia Letasiova |
| 18 | 223 | In vitro reconstructed model of human epidermis containing melanocytes for studying skin pigmentation and lightening | Silvia Letasiova |
| 19 | 150 | Transcriptomic Profiling of Native versus Human Skin Equivalent – cancelled | Eva-Anne Subileau |
| 20 | 93 | Measurement and simulation of transdermal delivery of topical drug formulations in a dynamic microfluidic diffusion chamber in health and disease | Franciska Erdő |
| 21 | 70 | Differences between potential skin and respiratory sensitizers tested by non-animal methods | Eliska Pacalova |
| 22 | 176 | Production of Fibroblast Coated Sutures and Examination of Their Applicability – Preliminary Study | Levente Goschler |
| 23 | 228 | Toxicological aspects of in vitro oral mucosa wound healing models | Marek Puskar |
| 24 | 233 | Eye damage reversibility in an in vitro model of bovine cornea to replace the Draize Test completely | Martina Benedetti |
| 25 | 240 | NOVEL PROTOCOL FOR IN VITRO BIOCOMPATIBILITY EVALUATION OF INTRAORAL MEDICAL DEVICES | Peter Pôbiš |
| 26 | 229 | Performance evaluation: incorporating GARD®skin assay into the OECD TG 497 Defined Approaches as a KE3 component | Tim Lindberg |
| 27 | 1 | JNK is activated in an Egfr-induced Drosophila lung tumor model and promotes cancer progression | Leizhi Shi |
| 28 | 161 | Optimization of a 3D multi-layer cell culture to study NSCLC chemoresistance mechanisms | Giulia Paties Montagner |
| 29 | 140 | Use of public transcriptional datasets for validating pulmonary in vitro models | Lorenz Latta |
| 30 | 6 | Quantitative AOP modeling of mucus hypersecretion using 3D cells for comparative risk estimation of tobacco products | Sakuya Ichikawa |
| 31 | 36 | From Flat to 3D Bioprinted Cell Cultures: Revolutionizing Breast Cancer Studies | Dorottya Moldvai |
| 32 | 31 | In vitro patient-derived tumour models – innovative 3D bioprinted long-term tissue cultures to test drug sensitivity | Dániel Sztankovics -YSTA awardee |
| 33 | 9 | Keeping an Eye on the Move: Tracking Cell Migration with Optical Imaging in 3D | Irem Duman -YSTA awardee |
| 34 | 52 | Targeting mitochondrial defects in a 3D-bioprinted LCHADD/VLCADD model | Antonia Degen |
| 35 | 4 | Systematic analysis of gut bacterial carcinogen biotransformation and its functional consequences | Boyao Zhang |
| 36 | 105 | Development of a modular fluid system to investigate the permeation of drugs from different BCS classes through an epithelial barrier to predict pharmacokinetics | Verena Vogel |
| 37 | 144 | Fluid dynamics optimisation in flow-through permeation test systems | Dorottya Kocsis |
| 38 | 30 | 3D human Vascular-on-a-Chip: Method development for the biological assessment of endothelial dysfunction and monocytes migration | Ayaka Hayashida |
| 39 | 51 | Coculture of Jurkat and THP-1 cell lines as a model for the evaluation of immunosuppressive properties of chemicals | Nina Franko |
| 40 | 127 | A replacement approach to animal model for the toxicity evaluation of autogenous vaccines | Martina Checco |
| 41 | 163 | Revealing Molecular Mechanisms of SARS-CoV-2 Spike Protein in Renal Epithelium through Microphysiological Modeling (MPS) | Maryna Somova |
| 42 | 208 | Assessing Male Reprotoxicity of Real-Life Mixtures Using Novel Approach Methodologies | Eliška Sychrová |
| 43 | 209 | Novel pull-down assay for efficient separation and identification of endocrine disruptors in complex environmental samples | Zuzana Toušová |
| 44 | 175 | Utilization of human lymphoblasted cell lines as an in vitro test system to unveil immunotoxicity of bisphenol A analogues and their mixtures | Tijana Markovič |
| 45 | 74 | Utilising experimental NAMs to assess genomic instability in liver models | Michael Burgum |
| 46 | 65 | HepG2 spheroids: A new testing approach for the determination of adverse effects of chemicals | Tim Ravnjak |
| 47 | 63 | Investigation of complex in vitro models using shotgun proteomics for the prediction of human-relevant data for anti-inflammatory drugs | Simone Lichtner |
| 48 | 134 | 3DTransfect – multi-scale drug-target validation by transfected 3D cell cultures | Vytaute Starkuviene |
| 49 | 206 | Multilayered nano-hydroxyapatite (nHA)/collagen (Coll) coated-PLGA scaffolds as in vitro tools to model metastatic prostate cancer in the bone and evaluate drug performance | Katie Ryan |
| 50 | 45 | Investigating pathological mechanical strain in ligament disease | Johannes Heidenberger -YSTA awardee |
| 51 | 255 | In vitro skeletal muscle model responsive to free fatty acids: A promising tool for testing toxins and metabolites | Xiaoying Chen |
| 52 | 189 | Daphnids as Early Warning Systems for Pharmaceutical Contamination: A Metabolomic Approach | Emma Rowan – EPAA awardee |
| 53 | 200 | The “Fish invitrome” as an animal-free alternative for the assessment of organ-specific toxicity in fish – a focus on environmental neurotoxicity | Jessica Bertoli |
| 54 | 214 | A composite bioink derived from lacrimal gland extracellular matrix and alginate | Luis Grumm |
